Prophylactic oophorectomy is presently the only effective method of ov
arian cancer prevention. This study reviews current data on how prophy
lactic oophorectomy (PO) should be used in different risk groups. It i
s estimated that 7% of ovarian cancer patients have positive family hi
story, of which 3-9% may end up having hereditary cancer syndromes. Wo
men in direct genetic lineage of family cancer syndromes may have up t
o 50% lifetime risk of ovarian cancer. Because of such a high risk, PO
is indicated for women with familial cancer syndromes after childbear
ing or the age of 35-40 at the latest. Most women with positive family
history of ovarian cancer do not have one of the recognized hereditar
y cancer syndromes. However, women with one or two affected relatives
do have an increased lifetime risk of ovarian cancer from a baseline o
f 1.6 to 5-7%. This risk is ndt high enough to warrant PO recommendati
on for a large number of women. After being properly informed and the
patient still desires surgical prevention (i.e., cancer phobia), PO th
en becomes an indicated procedure. In women without family history of
ovarian cancer, the role of PO remains controversial. The decision of
PO as a concurrent procedure to other indicated gynecologic surgeries
should depend on the individual patient and her ability to comply with
lifelong estrogen replacement therapy. (C) 1994 Academic Press, Inc.